APA (7th ed.) Citation

Gurrell, R., Dua, P., Feng, G., Sudworth, M., Whitlock, M., Reynolds, D. S., & Butt, R. P. (2018). A randomised, placebo-controlled clinical trial with the α2/3/5 subunit selective GABAA positive allosteric modulator PF-06372865 in patients with chronic low back pain. Pain (Amsterdam), 159(9), 1742-1751. https://doi.org/10.1097/j.pain.0000000000001267

Chicago Style (17th ed.) Citation

Gurrell, Rachel, Pinky Dua, Gang Feng, Maria Sudworth, Mark Whitlock, David S. Reynolds, and Richard P. Butt. "A Randomised, Placebo-controlled Clinical Trial with the α2/3/5 Subunit Selective GABAA Positive Allosteric Modulator PF-06372865 in Patients with Chronic Low Back Pain." Pain (Amsterdam) 159, no. 9 (2018): 1742-1751. https://doi.org/10.1097/j.pain.0000000000001267.

MLA (9th ed.) Citation

Gurrell, Rachel, et al. "A Randomised, Placebo-controlled Clinical Trial with the α2/3/5 Subunit Selective GABAA Positive Allosteric Modulator PF-06372865 in Patients with Chronic Low Back Pain." Pain (Amsterdam), vol. 159, no. 9, 2018, pp. 1742-1751, https://doi.org/10.1097/j.pain.0000000000001267.